Literature DB >> 8306504

The significance of blood levels of IgM, IgA, IgG and IgG subclasses in Sudanese visceral leishmaniasis patients.

A M Elassad1, S A Younis, M Siddig, J Grayson, E Petersen, H W Ghalib.   

Abstract

We developed an ELISA test using leishmania antigenic extracts to detect antigen-specific antibody responses, including subclass and isotype analysis, in visceral leishmaniasis (VL) patients from the Sudan. A total of 92 parasitologically proven patients were compared with cutaneous leishmaniasis, schistosomiasis, malaria, onchocerciasis and tuberculosis patients, as well as with healthy endemic and non-endemic controls. Some VL patients were examined before and after chemotherapy. VL patients showed significantly higher IgG responses compared with all other groups (93.4% sensitivity, 93.7% specificity), and higher (but not significantly) IgM responses. All groups showed low IgA levels. All IgG subclasses, IgG1, 2, 3, and 4, showed higher levels in patients than all other groups, with IgG1 and IgG3 levels being significantly reduced following treatment. The rank order for specificity and sensitivity for IgG subclasses was IgG3 > IgG1 > IgG2 > IgG4.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8306504      PMCID: PMC1534916          DOI: 10.1111/j.1365-2249.1994.tb06526.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  An improved serodiagnostic procedure for visceral leishmaniasis.

Authors:  S G Reed; W G Shreffler; J M Burns; J M Scott; M da G Orge; H W Ghalib; M Siddig; R Badaro
Journal:  Am J Trop Med Hyg       Date:  1990-12       Impact factor: 2.345

2.  The profile of IgG and IgG subclasses of onchocerciasis patients.

Authors:  T H Dafa'alla; H W Ghalib; A Abdelmageed; J F Williams
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

3.  A comparison of the direct agglutination test and enzyme-linked immunosorbent assay in the sero-diagnosis of leishmaniasis in the Sudan.

Authors:  S H el Safi; D A Evans
Journal:  Trans R Soc Trop Med Hyg       Date:  1989 May-Jun       Impact factor: 2.184

4.  Antibody kinetics in kala-azar in response to treatment.

Authors:  A B Neogy; A Nandy; B Ghosh Dastidar; A B Chowdhury
Journal:  Ann Trop Med Parasitol       Date:  1987-12

5.  Interleukin 10 production correlates with pathology in human Leishmania donovani infections.

Authors:  H W Ghalib; M R Piuvezam; Y A Skeiky; M Siddig; F A Hashim; A M el-Hassan; D M Russo; S G Reed
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

6.  Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis.

Authors:  F P Heinzel; M D Sadick; S S Mutha; R M Locksley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

7.  Kala-azar in displaced people from southern Sudan: epidemiological, clinical and therapeutic findings.

Authors:  E E Zijlstra; M S Ali; A M el-Hassan; I A el-Toum; M Satti; H W Ghalib; E Sondorp; A Winkler
Journal:  Trans R Soc Trop Med Hyg       Date:  1991 May-Jun       Impact factor: 2.184

8.  Epidemic visceral leishmaniasis in southern Sudan: identity and systematic position of the parasites from patients and vectors.

Authors:  R W Ashford; J Seaman; J Schorscher; F Pratlong
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 Jul-Aug       Impact factor: 2.184

9.  Kala-azar in western Upper Nile province in the southern Sudan and its spread to a nomadic tribe from the north.

Authors:  A M el-Hassan; F A Hashim; M S Ali; H W Ghalib; E E Zijlstra
Journal:  Trans R Soc Trop Med Hyg       Date:  1993 Jul-Aug       Impact factor: 2.184

10.  Distinct IgG1 and IgG3 subclass responses to two streptococcal protein antigens in man: analysis of antibodies to streptolysin O and M protein using standardized subclass-specific enzyme-linked immunosorbent assays.

Authors:  A E Falconer; R Carson; R Johnstone; P Bird; M Kehoe; J E Calvert
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

View more
  17 in total

Review 1.  Systematic review of biomarkers to monitor therapeutic response in leishmaniasis.

Authors:  Anke E Kip; Manica Balasegaram; Jos H Beijnen; Jan H M Schellens; Peter J de Vries; Thomas P C Dorlo
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  A novel Leishmania infantum recombinant antigen which elicits interleukin 10 production by peripheral blood mononuclear cells of patients with visceral leishmaniasis.

Authors:  I Suffia; B Ferrua; X Stien; B Mograbi; P Marty; D Rousseau; K Fragaki; J Kubar
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages.

Authors:  Ziyan Yang; David M Mosser; Xia Zhang
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

4.  Detection of specific antibody isotypes and subtypes before and after treatment of American visceral leishmaniasis.

Authors:  V L da Matta; S Hoshino-Shimizu; R Dietze; C E Corbett
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

5.  Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation.

Authors:  Eszter Deak; Asha Jayakumar; Ka Wing Cho; Karen Goldsmith-Pestana; Blaise Dondji; John D Lambris; Diane McMahon-Pratt
Journal:  Eur J Immunol       Date:  2010-05       Impact factor: 5.532

6.  Differential decline in Leishmania membrane antigen-specific immunoglobulin G (IgG), IgM, IgE, and IgG subclass antibodies in Indian kala-azar patients after chemotherapy.

Authors:  K Anam; F Afrin; D Banerjee; N Pramanik; S K Guha; R P Goswami; S K Saha; N Ali
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

7.  Preclinical diagnosis of American visceral leishmaniasis during early onset of human Leishmania (L.) infantum chagasi-infection.

Authors:  Luciana Vieira do Rêgo Lima; Patrícia Karla Santos Ramos; Marliane Batista Campos; Thiago Vasconcelos dos Santos; Claudia Maria de Castro Gomes; Márcia Dalastra Laurenti; Carlos Eduardo Pereira Corbett; Fernando Tobias Silveira
Journal:  Pathog Glob Health       Date:  2014-12-09       Impact factor: 2.894

8.  Distribution of IgG subclasses in antimonial unresponsive Indian kala-azar patients.

Authors:  M Chatterjee; K Basu; D Basu; D Bannerjee; N Pramanik; S K Guha; R P Goswami; S K Saha; C Mandal
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

9.  The cured immune phenotype achieved by treatment of visceral leishmaniasis in the BALB/c mouse with a nonionic surfactant vesicular formulation of sodium stibogluconate does not protect against reinfection.

Authors:  K C Carter; A J Baillie; A B Mullen
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

10.  Characterization of immunoglobulin G and its subclass response to Indian kala-azar infection before and after chemotherapy.

Authors:  Rajesh Ravindran; Khairul Anam; Bibhas C Bairagi; Bibhuti Saha; Netai Pramanik; Subhasis K Guha; Rama P Goswami; Dwijadas Banerjee; Nahid Ali
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.